MET and neoplasm: Functionally, the BsAb enhanced interferon (IFN)-γ production by 2-3 folds compared to control IgG, inhibited c-MET pathway activation, significantly reduced tumor cell proliferation, and exhibited dose-dependent cytotoxicity against MKN45 cells.